Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ototoxicity.

L P Rybak1, V Ramkumar

  • 1Department of Surgery, Southern Illinois University, School of Medicine, Springfield, Illinois 62794-9653, USA. lrybak@siumed.edu

Kidney International
|July 27, 2007
PubMed
Summary
This summary is machine-generated.

Drug-induced hearing loss from aminoglycosides and cisplatin may be preventable. Antioxidants show promise in protecting the inner ear, with one clinical trial demonstrating reduced hearing loss when aspirin was combined with gentamicin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis, crystal structure and <i>in silico</i> studies of novel 2,4-dimethoxy-tetrahydropyrimido[4,5-<i>b</i>]quinolin-6(7<i>H</i>)-ones.

RSC advances·2022
Same author

Influence of lattice strain on Fe<sub>3</sub>O<sub>4</sub>@carbon catalyst for the destruction of organic dye in polluted water using a combined adsorption and Fenton process.

RSC advances·2022
Same author

Metallaboranes from Metal Carbonyl Compounds and Their Utilization as Catalysts for Alkyne Cyclotrimerization.

ChemPlusChem·2020
Same author

New Trinuclear Complexes of Group 6, 8, and 9 Metals with a Triply Bridging Borylene Ligand.

Chemistry (Weinheim an der Bergstrasse, Germany)·2016
Same author

Crystal structure of 2,6-bis-(2,5-di-meth-oxy-phen-yl)-3,5-di-methyl-piperidin-4-one.

Acta crystallographica. Section E, Structure reports online·2014
Same author

Crystal structure of 2,4-bis-(2-chloro-phen-yl)-7-tert-pent-yl-3-aza-bicyclo[3.3.1]nonan-9-one.

Acta crystallographica. Section E, Structure reports online·2014
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
See all related articles

Area of Science:

  • Ototoxicity research
  • Pharmacology
  • Otolaryngology

Background:

  • Aminoglycoside antibiotics and cisplatin are common therapeutic agents with known nephrotoxic and ototoxic side effects.
  • These drugs damage outer hair cells in the cochlea, leading to high-frequency sensorineural hearing loss.
  • The ototoxic mechanisms involve the generation of reactive oxygen species within the cochlea, triggering cell death pathways.

Purpose of the Study:

  • To review recent findings on the mechanisms of drug-induced hearing loss.
  • To explore potential protective strategies against ototoxicity.
  • To discuss the clinical implications and challenges of implementing protective agents.

Main Methods:

  • Review of existing literature on aminoglycoside and cisplatin ototoxicity.

Related Experiment Videos

  • Examination of experimental studies on protective agents, including antioxidants.
  • Analysis of a specific double-blind, placebo-controlled clinical trial in China.

    • Main Results:

    • Reactive oxygen species are implicated in the ototoxicity of both drug classes.
    • Antioxidants have shown protective effects in animal models.
    • A clinical trial demonstrated that aspirin administration reduced gentamicin-induced hearing loss.

    Conclusions:

    • Drug-induced hearing loss is a significant concern with certain therapeutic agents.
    • Protective agents, particularly antioxidants, offer potential for preventing ototoxicity.
    • Careful administration strategies, such as middle ear injection, may be necessary to avoid compromising therapeutic efficacy.